Patents by Inventor Benoit Ledoussal

Benoit Ledoussal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050101589
    Abstract: Compounds having the general structure: which are effective antimicrobial agents.
    Type: Application
    Filed: December 3, 2004
    Publication date: May 12, 2005
    Inventors: Benoit Ledoussal, Ji-In Almstead, Jeffrey Gray
  • Patent number: 6849740
    Abstract: Compounds having the general structure which are effective antimicrobial agents.
    Type: Grant
    Filed: March 18, 2003
    Date of Patent: February 1, 2005
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20040038975
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: June 16, 2003
    Publication date: February 26, 2004
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20040029882
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: July 30, 2003
    Publication date: February 12, 2004
    Applicant: The Procter & Gamble Co.
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6645981
    Abstract: Compounds of the following formula: are effective antimicrobial agents.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: November 11, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20030207862
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: March 19, 2003
    Publication date: November 6, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20030171587
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: November 22, 2002
    Publication date: September 11, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Sean M. Flaim
  • Patent number: 6509349
    Abstract: Compounds having the general structure: are effective antimicrobial agents.
    Type: Grant
    Filed: December 14, 2001
    Date of Patent: January 21, 2003
    Assignee: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Sean M. Flaim
  • Publication number: 20030008894
    Abstract: Compounds of the following formula: 1
    Type: Application
    Filed: December 14, 2001
    Publication date: January 9, 2003
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Xiufeng Eric Hu, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20020173501
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: February 28, 2002
    Publication date: November 21, 2002
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6387928
    Abstract: Compounds having the general structure: which are effective antimicrobial agents.
    Type: Grant
    Filed: August 15, 2001
    Date of Patent: May 14, 2002
    Assignee: The Procter & Gamble Co.
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Publication number: 20020049192
    Abstract: Compounds having the general structure: 1
    Type: Application
    Filed: August 15, 2001
    Publication date: April 25, 2002
    Applicant: The Procter & Gamble Company
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6348624
    Abstract: The subject invention involves processes for making 2,4-difluoro-3-Q1-benzoic acid, wherein Q1 is derived from an electrophilic reagent, comprising the steps of: (a) treating 1-bromo-2,4-difluorobenzene with a strong, non-nucleophilic base; then treating with an electrophilic reagent which provides Q1, or a functional moiety which is then transformed to Q1, producing 1-bromo-2,4-difluoro-3-Q1-benzene; (b) treating the 1-bromo-2,4-difluoro-3-Q1-benzene with an alkali or alkaline earth metal or organometallic reagent; then treating with carbon dioxide, or with a formylating agent followed by oxidation, to produce 2,4-difluoro-3-Q1-benzoic acid. The subject invention also involves optional additional steps to further modify Q1, or to substitute a non-hydrogen moiety at the 5-position, at the 6-position, or at both, of the phenyl ring of the 2,4-difluoro-3-Q1-benzoic acid.
    Type: Grant
    Filed: December 17, 1998
    Date of Patent: February 19, 2002
    Assignee: The Procter & Gamble Co.
    Inventors: Benoit Ledoussal, Xiaomin Sharon Zheng, Ji-In Kim Almstead, Jeffrey Lyle Gray
  • Patent number: 6329391
    Abstract: This invention relates to novel antimicrobial compounds of formula; wherein X, R1, R3, R5, R6, and R8 are defined in the claims, and to their optical isomers, diastereomers or enantiomers, as well as pharmaceutically-acceptable salts, hydrates, and biohydrolyzable esters, amides and imides thereof, and to compositions and uses of such compounds. The invention also relates to compounds derived from these compounds having antimicrobial uses.
    Type: Grant
    Filed: March 10, 1999
    Date of Patent: December 11, 2001
    Assignee: The Procter & Gamble Co.
    Inventors: Benoit Ledoussal, Ji-In Kim Almstead, Jeffrey Lyle Gray, Xiufeng Eric Hu